Two patients with "pure akinesia" who showed the characteristic changes of progressive supranuclear palsy (PSP) at necropsy are described. They had akinesia but no rigidity or tremor, and ophthalmoplegia was not observed during the course of illness. The symptoms of "pure akinesia" was not improved by levodopa therapy but was considerably improved by L-threo-3,4-dihydroxyphenylserine. At necropsy, pathological findings were not different from those reported for PSP. It is suggested that "pure akinesia" is an atypical manifestation of PSP, and that norepinephrinergic neurons may be involved in some types of PSP.
"Pure akinesia" is a rare syndrome characterised by the freezing of gait and pulsion symptoms without rigidity or tremor, and by lack of response to levodopa therapy. ' 2 Several reports have shown L-threo-3,4-dihydroxyphenylserine(L-DOPS), a synthetic precursor of norepinephrine (NE), to be dramatically effective in treating this condition.34 This suggests that the norepinephrinergic neurons of the central nervous system (CNS) may be part of the neurochemical background of the disease. "Pure akinesia" therefore has been seen as a new condition or specific form of Parkinsonism.'45 As there have been few anatomical studies, the classification of this syndrome is still not clear.
We report the cases of two patients who showed "pure akinesia" and who had good responses to L-DOPS as a clinical manifestation, but who on postmortem examination were found to have had progressive supranuclear palsy (PSP). The freezing phenomenon dramatically improved when he underwent L-DOPS therapy (600 mg/day); the time of initial hesitation in walking decreased considerably and micrographia improved. Two years after the onset of his illness, he died of oesophageal cancer.
Patient 2
A 62 year old man with no history of neurological disease noticed an increasingly frequent inability to open his eyes. Over the next two years, he developed frozen gait and had frequent falls. His eye symptom and gait disturbance persisted despite treatment with carbidopa-levodopa and with trihexyphenidyl. At a neurological examination two years before his death, he showed a mask-like face and apraxia on opening his eyelids. No restriction of eye movement or ptosis was observed. His speech was low pitched and monotonous, and often festinating. There was no evidence of dementia, rigidity or tremor. His gait was considerably disturbed, freezing occurring on the initiation of movement and on turning. Pulsion symptoms were observed in each direction. An examination of his cerebrospinal fluid and an electroencephalogram showed no abnormality. A CT scan disclosed mild cerebral atrophy. After treatment with L-DOPS (600 mg/day), the time required to open his eyelid decreased from more than four minutes to less than 30 seconds, and his frozen gait improved slightly. One year later, he showed mild dementia and marked bradykinesia. Magnetic resonance imaging revealed no further abnormality except minimal atrophy of the tegmentum of the midbrain (fig 1) . Six months before his death he developed a persistent cough; a chest radiograph disclosed lung cancer. A neurological examination two weeks before his death revealed no abnormality in his oculomotor function, and no axial rigidity or tremor.
Neuropathologicalfindings
The brains of the two patients weighed 1125 and 1180 gm. Gross examinations of both brains showed no external abnormalities, apart from a degree of atrophy that was mainly in the frontal lobe. The sections In both cases microscopic examinations revealed the characteristic changes associated with PSP: cell loss, gliosis and neurofibrillary degeneration in a typical distribution (table) . The cerebral cortex showed only mild cell loss with few senile plaques and no NFTs. In contrast, severe degeneration associated with cell loss, gliosis and NFTs had taken place in the globus pallidum, subthalamic nucleus, substantia nigra and pontine tegmentum (fig 2) . In addition, many neuropil threads were present in the substantia nigra in both brains (fig 3) . There was no apparent cell loss in the locus ceruleus, but many intracelular NFTs showed up on anti-tau immunostaining. Vacuolar degeneration was seen in the oculomotor nucleus and abducent nucleus in patient 2. There were no Lewy bodies in either brain.
Discussion
The freezing phenomenon as the predominant feature of akinesia is usually associated with the following conditions: 1) an almost pure akinetic syndrome without rigidity or tremor (as reported by Barbeau9), for which levodopa is effective and which suggests a deficiency of dopamine in the striatum; 2) pure akinesia characterised by the freezing phenomenon with no rigidity or tremor (as reported by Narabayashi et all), in which the lack of response to levodopa treatment suggests that it is unlikely that a deficiency in dopamine is the cause; 3) long-standing Parkinsonism treated chronically with levodopa;'""2 and 4) the freezing phenomenon related to bradykinesia, itself. In our cases, no symptoms indicative of Parkinsonism other than akinesia were observed, nor did the freezing phenomenon improve when levodopa therapy was given. This corresponds 
